Lewis Thomas L, Furness Hugh N, Miller George W, Parsons Nicholas, Seers Kate, Underwood Martin, Metcalfe Andrew J
Department of Trauma and Orthopaedic Surgery, University Hospital Coventry & Warwick, Coventry, UK.
St George's University of London, London, UK.
BMJ Open. 2018 Apr 17;8(4):e020486. doi: 10.1136/bmjopen-2017-020486.
Efficient adoption of clinically effective novel surgical innovations has great potential benefits for patients. Factors affecting the adoption of surgical innovation are not well understood and proposed models of adoption do not accurately correlate with historical evidence. This protocol is for a systematic review that aims to identify the qualitative evidence relating to surgeon views regarding the adoption of novel surgical innovation into clinical practice.
A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance will be performed. Two independent reviewers will search the following databases: MEDLINE, Embase, Science Direct, Scopus, Web of Science and the Cochrane Library of Systematic Reviews. Inclusion criteria are studies which report on the views of surgeons who adopt a novel surgical innovation into clinical practice. Each article will be screened for inclusion and assessed according to a Critical Appraisal Skills Programme tool. Data will be synthesised and analysed according to thematic analysis. Given the anticipated yield of a small heterogeneous body of evidence meeting the eligibility criteria for the review, a narrative-based summary is planned.
This review does not require formal ethical approval as it does not involve direct patient contact or patient-identifiable data. The results of this review will be published in a peer-reviewed journal and presented at relevant conferences. The results will also inform an empirical qualitative study exploring surgeon and other stakeholder views regarding the introduction of novel surgical technology and procedures into clinical practice.
CRD42017076715.
有效采用具有临床疗效的新型外科创新技术对患者具有巨大潜在益处。影响外科创新技术采用的因素尚未得到充分理解,且所提出的采用模型与历史证据并不准确相关。本方案旨在进行一项系统综述,以确定与外科医生关于将新型外科创新技术应用于临床实践的观点相关的定性证据。
将按照系统评价和Meta分析的首选报告项目指南进行系统综述。两名独立评审员将检索以下数据库:MEDLINE、Embase、Science Direct、Scopus、科学网和Cochrane系统评价图书馆。纳入标准为报告将新型外科创新技术应用于临床实践的外科医生观点的研究。每篇文章将接受纳入筛选,并根据批判性评价技能计划工具进行评估。数据将根据主题分析进行综合和分析。鉴于预期符合综述纳入标准的证据体量小且异质性强,计划进行基于叙述的总结。
本综述无需正式伦理批准,因为它不涉及直接接触患者或可识别患者的数据。本综述结果将发表在同行评审期刊上,并在相关会议上展示。研究结果还将为一项实证定性研究提供信息,该研究将探讨外科医生和其他利益相关者对于将新型外科技术和程序引入临床实践的观点。
PROSPERO注册号:CRD42017076715。